M&A Deal Summary

Wockhardt Acquires Negma Laboratories SAS

On March 5, 2007, Wockhardt acquired life science company Negma Laboratories SAS for 265M USD

Acquisition Highlights
  • This is Wockhardt’s 1st transaction in the Life Science sector.
  • This is Wockhardt’s largest (disclosed) transaction.
  • This is Wockhardt’s 1st transaction in France.

M&A Deal Summary
Date 2007-03-05
Target Negma Laboratories SAS
Sector Life Science
Buyer(s) Wockhardt
Deal Type Add-on Acquisition
Deal Value 265M USD

Target

Negma Laboratories SAS

Velizy-Villacoublay, France
Negma Laboratories SAS operates pharmaceutical company.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Wockhardt

Mumbai,, India
Category Company
Founded 1999
Sector Life Science
Employees8,600
DESCRIPTION

Wockhardt is a high technology global pharmaceuticals and biotechnology major with innovative multi-disciplinary research and development programmes. It has 5 research centres and 21 world-class manufacturing plants in India, USA, UK, France and Ireland.

DEAL STATS #
Overall 1 of 2
Sector (Life Science) 1 of 2
Type (Add-on Acquisition) 1 of 2
Country (France) 1 of 1
Year (2007) 1 of 2
Size (of disclosed) 1 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-10-24 Morton Grove Pharmaceuticals

Morton Grove, Illinois, United States

Morton Grove Pharmaceuticals, Inc. is a fully integrated generic and specialty pharmaceutical company focused on oral liquid and topical liquid prescription drugs.

Buy $38M
Mergr

Product

Company

Legal